- Home
- PVL vs NTRB Comparison
PVL vs NTRB Comparison
Compare PVL & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVL
- NTRB
- Stock Information
- Founded
- PVL 2011
- NTRB 2016
- Country
- PVL United States
- NTRB United States
- Employees
- PVL N/A
- NTRB N/A
- Industry
- PVL Oil & Gas Production
- NTRB Industrial Specialties
- Sector
- PVL Energy
- NTRB Health Care
- Exchange
- PVL Nasdaq
- NTRB Nasdaq
- Market Cap
- PVL 51.1M
- NTRB 77.9M
- IPO Year
- PVL N/A
- NTRB N/A
- Fundamental
- Price
- PVL $1.38
- NTRB $4.08
- Analyst Decision
- PVL
- NTRB
- Analyst Count
- PVL 0
- NTRB 0
- Target Price
- PVL N/A
- NTRB N/A
- AVG Volume (30 Days)
- PVL 75.7K
- NTRB 30.2K
- Earning Date
- PVL 01-01-0001
- NTRB 12-04-2024
- Dividend Yield
- PVL 6.23%
- NTRB N/A
- EPS Growth
- PVL N/A
- NTRB N/A
- EPS
- PVL 0.20
- NTRB N/A
- Revenue
- PVL $3,142,081.00
- NTRB $2,021,771.00
- Revenue This Year
- PVL N/A
- NTRB N/A
- Revenue Next Year
- PVL N/A
- NTRB N/A
- P/E Ratio
- PVL $6.81
- NTRB N/A
- Revenue Growth
- PVL N/A
- NTRB N/A
- 52 Week Low
- PVL $1.03
- NTRB $2.22
- 52 Week High
- PVL $1.96
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- PVL 29.68
- NTRB 40.82
- Support Level
- PVL $1.31
- NTRB $3.87
- Resistance Level
- PVL $1.54
- NTRB $4.80
- Average True Range (ATR)
- PVL 0.05
- NTRB 0.51
- MACD
- PVL -0.01
- NTRB 0.04
- Stochastic Oscillator
- PVL 25.93
- NTRB 21.21
About PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production the sale of oil and natural gas production from primarily non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.